iodine and Familial Nonmedullary Thyroid Cancer
iodine has been researched along with Familial Nonmedullary Thyroid Cancer in 55 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"In the present study, we investigated whether bisphenol A (BPA) levels and excessive iodine intake were associated with papillary thyroid carcinoma (PTC) and nodular goiter (NG)." | 9.24 | Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma. ( Jiang, F; Jiang, L; Xie, Y; Zhang, J; Zhang, X; Zhou, Z, 2017) |
"To develop and validate 2 iodine maps based radiomics nomograms for preoperatively predicting cervical lymph node metastasis (LNM) and central lymph node metastasis (CLNM) in papillary thyroid cancer (PTC)." | 8.12 | Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. ( Ge, YQ; Hu, H; Shen, MP; Si, Y; Su, GY; Tao, XW; Wu, FY; Xu, XQ; Zhou, Y, 2022) |
"The aim of this study was to retrospectively identify the effect of iodine on the papillary thyroid cancer (PTC) process and investigate the risk clinicopathologic characteristics of cervical lymph node metastasis (CLNM) for achieving a better preventive strategy of PTC." | 8.02 | High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients. ( Fan, L; Guo, L; He, Q; Miao, S; Sun, D; Sun, J; Sun, Q; Tian, Q; Wang, F; Xiu, C; Yang, X; Yuan, Z, 2021) |
"An abrupt increase of thyroid cancer has been witnessed paralleling the supplemented iodine intake in formerly iodine-deficient countries." | 5.62 | Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study. ( Kang, W; Li, K; Liu, Z; Ouyang, S; Sun, J; Wang, X; Ye, X; Yu, J; Zeng, Z; Zhang, Z, 2021) |
"In the present study, we investigated whether bisphenol A (BPA) levels and excessive iodine intake were associated with papillary thyroid carcinoma (PTC) and nodular goiter (NG)." | 5.24 | Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma. ( Jiang, F; Jiang, L; Xie, Y; Zhang, J; Zhang, X; Zhou, Z, 2017) |
"To develop and validate 2 iodine maps based radiomics nomograms for preoperatively predicting cervical lymph node metastasis (LNM) and central lymph node metastasis (CLNM) in papillary thyroid cancer (PTC)." | 4.12 | Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. ( Ge, YQ; Hu, H; Shen, MP; Si, Y; Su, GY; Tao, XW; Wu, FY; Xu, XQ; Zhou, Y, 2022) |
"The aim of this study was to retrospectively identify the effect of iodine on the papillary thyroid cancer (PTC) process and investigate the risk clinicopathologic characteristics of cervical lymph node metastasis (CLNM) for achieving a better preventive strategy of PTC." | 4.02 | High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients. ( Fan, L; Guo, L; He, Q; Miao, S; Sun, D; Sun, J; Sun, Q; Tian, Q; Wang, F; Xiu, C; Yang, X; Yuan, Z, 2021) |
" After drawing a region of interest on the DECT-derived iodine maps, the obtained iodine concentration values of thyroid nodules (IC_N) and normalized IC_N were compared between 3 groups: papillary thyroid carcinoma (PTC), benign nodule, and cyst." | 3.91 | Dual-energy CT iodine quantification for characterizing focal thyroid lesions. ( Kim, B; Lee, DH; Lee, KY; Lee, YH; Ryoo, I; Seo, HS; Suh, SI; Yang, KS; You, SH, 2019) |
"With thyroid carcinoma the decision to use radioactive iodine (RAI) ablation depends on the risk of poor outcomes." | 3.83 | Radioactive iodine treatment for node negative papillary thyroid cancer with capsular invasion only: Results of a large retrospective study. ( Ahn, YE; Choi, HJ; Chung, WS; Jeon, YW; Suh, YJ, 2016) |
"To determine the possible adverse effects of radioactive iodine (RAI) treatment on the olfactory functions of patients with differentiated thyroid carcinoma." | 3.83 | The effects of radioactive iodine therapy on olfactory function. ( Deniz Tuna, E; Muhammet, Y; Ozgur, Y; Suat, B; Tevfik Fikret, C, 2016) |
"Iodine in iodinated contrast agents (ICAs) interferes with radioactive iodine treatment (RAIT) and diagnostic scans in patients with differentiated thyroid carcinoma (DTC) because it can compete with ¹³¹I." | 3.80 | The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment. ( Bae, JC; Cho, YY; Choi, JH; Chung, JH; Jin, SM; Joung, JY; Kim, NK; Kim, SW; Kim, TH; Lee, SY; Park, SM; Sohn, SY, 2014) |
"Childhood exposure to iodine-131 from the 1986 nuclear accident in Chernobyl, Ukraine, led to a sharp increase in papillary thyroid carcinoma (PTC) incidence in regions surrounding the reactor." | 3.79 | RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. ( Bogdanova, TI; Brenner, AV; Hatch, M; Leeman-Neill, RJ; Little, MP; Mabuchi, K; Nikiforov, YE; Tronko, MD; Zurnadzy, LY, 2013) |
" In multivariate assessment an exceed of the upper limit of norm was associated with a younger age (under 11 years), living in areas with moderate iodine deficiency, radiogenic history, the presence of Hashimoto thyroiditis, variant of tumor growth and the degree of intratumoral fibrosis." | 3.79 | [The increase of non-cancerous thyroid tissue in children and adolescents operated for papillary thyroid cancer: related factors]. ( Demidchik, IuE; Fridman, MV; Kras'ko, OV; Man'kovskaia, SV; Savva, NN, 2013) |
"The effect of iodine on papillary thyroid cancer (PTC) has been controversial for many years." | 2.82 | The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis. ( Aihaiti, R; Chen, D; Feng, C; Li, Q; Teng, W; Zhang, F; Zhang, X; Zhao, X, 2022) |
"Iodine excess has been suggested as an exogenous risk factor of papillary thyroid cancer (PTC)." | 2.55 | Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta-analysis. ( Chai, YJ; Choi, JY; Hwang, Y; Kim, SJ; Lee, JH; Lee, KE; Park, SK; Song, RY; Yi, JW; Yu, HW, 2017) |
"Herein, we present 2 patients with papillary thyroid carcinoma, follicular variant, and cervical lymph node involvement." | 2.52 | Incidentally Visualization of the Thymus on Whole-Body Iodine Scintigraphy: Report of 2 Cases and Review of the Latest Insights. ( Farhoudi, F; Haghighatafshar, M, 2015) |
"HT is frequently associated with papillary thyroid carcinoma and may indeed be a risk factor for developing this type of cancer." | 2.48 | Hashimoto thyroiditis: a century later. ( Ahmed, R; Akhtar, M; Al-Shaikh, S, 2012) |
"A total of 452 patients with papillary thyroid cancer were retrospectively recruited between June 2017 and June 2020." | 1.72 | Iodine Maps from Dual-Energy CT to Predict Extrathyroidal Extension and Recurrence in Papillary Thyroid Cancer Based on a Radiomics Approach. ( Ge, YQ; Shen, MP; Si, Y; Su, GY; Tao, XW; Wu, FY; Xu, XQ; Zhou, Y, 2022) |
"In this study, a total of 33 papillary thyroid cancer (PTC) patients from areas with iodine excess and 32 PTC patients from areas with adequate iodine were recruited, and their cancerous tissue and paracancerous tissue were collected." | 1.62 | Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions. ( Fan, L; Guo, L; He, Q; Liu, Z; Sun, D; Sun, J; Sun, Q; Tian, Q; Wang, F; Xiu, C; Zhao, H, 2021) |
"An abrupt increase of thyroid cancer has been witnessed paralleling the supplemented iodine intake in formerly iodine-deficient countries." | 1.62 | Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study. ( Kang, W; Li, K; Liu, Z; Ouyang, S; Sun, J; Wang, X; Ye, X; Yu, J; Zeng, Z; Zhang, Z, 2021) |
"miR-146b-5p is overexpressed in papillary thyroid carcinoma (PTC) and is thought to be a related diagnostic marker." | 1.56 | Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation. ( Cui, R; Ding, Z; Fan, J; Jiang, W; Liu, C; Liu, Y; Pan, Y; Shi, B; Tang, J; Yu, X; Yun, W; Zheng, T, 2020) |
"PTC: Papillary thyroid carcinoma FNPA: Fine needle puncture aspiration." | 1.51 | Cervical thyroid remnant consistent with papillary carcinoma as an incidental finding in a patient with benign total thyroidectomy ten years prior. ( Ochagavía Cámara, S; Rivera Alonso, D; Ruano Campos, A, 2019) |
"Thyroid nodules have become a common clinical problem, and the clinical importance of thyroid nodules lies in the determination of thyroid cancer." | 1.48 | High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk. ( Huang, T; Li, H; Zhao, H, 2018) |
"The incidence of thyroid cancer has recently increased worldwide." | 1.48 | A case-control study of urinary levels of iodine, perchlorate and thiocyanate and risk of papillary thyroid cancer. ( Fan, S; Fang, C; Li, J; Liu, L; Liu, S; Liu, X; Ni, S; Wu, Y; Zhang, L; Zhao, Y, 2018) |
"Papillary thyroid cancer (PTC) accounts for more than 97 % of thyroid cancer and 80% or more PTC cases harbor the BRAF mutation in Korea." | 1.48 | Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area. ( Byun, DW; Chung, JH; Kim, HJ; Kim, SW; Min, YK; Park, HK; Suh, K; Yoo, MH, 2018) |
"Serum miRNAs profiles between papillary thyroid carcinoma (PTC) patients with non-(131)I and (131)I-avid lung metastases are differentially expressed." | 1.43 | miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway. ( Luo, QY; Qiu, ZL; Shen, CT; Song, HJ; Wei, WJ, 2016) |
"We examined thyroid cancer incidence patterns using data from the Sao Paulo Cancer Registry (SPCR) in Brazil and the National Cancer Institute's Surveillance Epidemiology End Results (SEER) program in the United States." | 1.39 | Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. ( Aschebrook-Kilfoy, B; Devesa, SS; Neta, G; Ron, E; Veiga, LH, 2013) |
"A PTMC was defined as a papillary thyroid carcinoma with a diameter ≤ 10 mm." | 1.38 | Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. ( Charitoudis, G; Kapetanakis, S; Karakostas, E; Karatzas, T; Kouraklis, G; Stavrianaki, A; Vasileiadis, I, 2012) |
"The incidence of thyroid cancer has increased within the last decade, an increase that is accounted for mostly by differentiated tumors." | 1.38 | Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. ( Ceda, GP; Ceresini, G; Corcione, L; Gilli, A; Michiara, M; Sgargi, P; Silini, E; Teresi, G; Usberti, E, 2012) |
"Papillary thyroid cancer (PTC) incidence increased dramatically in children after the Chernobyl accident, providing a unique opportunity to investigate the molecular features of radiation-induced thyroid cancer." | 1.38 | A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. ( Bogdanova, T; Detours, V; Dom, G; Dumont, JE; Jarzab, B; Maenhaut, C; Oczko-Wojciechowska, M; Tarabichi, M; Thomas, G; Unger, K, 2012) |
Research
Studies (55)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 35 (63.64) | 24.3611 |
2020's | 20 (36.36) | 2.80 |
Authors
Authors | Studies |
---|---|
Maciel, J | 1 |
Cavaco, D | 1 |
Silvestre, C | 1 |
Simões Pereira, J | 1 |
Vilar, H | 1 |
Leite, V | 1 |
Xu, XQ | 3 |
Zhou, Y | 3 |
Su, GY | 3 |
Tao, XW | 2 |
Ge, YQ | 3 |
Si, Y | 3 |
Shen, MP | 3 |
Wu, FY | 3 |
Zou, Y | 1 |
Shi, Y | 1 |
Sun, F | 1 |
Liu, J | 5 |
Guo, Y | 1 |
Zhang, H | 1 |
Lu, X | 1 |
Gong, Y | 1 |
Xia, S | 1 |
Zhang, J | 2 |
Zhao, A | 1 |
Jia, X | 1 |
Li, X | 1 |
Liang, Y | 1 |
Liu, Y | 3 |
Xie, X | 1 |
Qu, X | 1 |
Wang, Q | 1 |
Zhang, Y | 1 |
Gao, R | 1 |
Yu, Y | 1 |
Yang, A | 1 |
Zhang, X | 5 |
Zhang, F | 3 |
Li, Q | 3 |
Aihaiti, R | 3 |
Feng, C | 3 |
Chen, D | 3 |
Zhao, X | 3 |
Teng, W | 3 |
Xu, S | 3 |
Huang, H | 3 |
Huang, Y | 3 |
Qian, J | 3 |
Wang, X | 4 |
Xu, Z | 3 |
Liu, S | 4 |
Luo, ZY | 1 |
Qin, JW | 1 |
Fang, JG | 1 |
Zheng, C | 1 |
Gong, WB | 1 |
Hei, H | 1 |
Lin, YY | 1 |
Hsieh, YS | 1 |
Hwang, Y | 2 |
Oh, HK | 1 |
Chung, JH | 4 |
Kim, SW | 5 |
Kim, JH | 2 |
Kim, JS | 1 |
Shin, MH | 1 |
Horiuchi, K | 1 |
Fujimoto, M | 1 |
Hidenori, K | 1 |
Yoshida, Y | 1 |
Noguchi, E | 1 |
Omi, Y | 1 |
Okamoto, T | 1 |
Zhang, D | 1 |
Xu, X | 1 |
Li, J | 2 |
Yang, X | 2 |
Sun, J | 5 |
Wu, Y | 2 |
Qiao, H | 1 |
Xiu, C | 3 |
He, Q | 3 |
Zhao, HJ | 1 |
Yuan, ZN | 1 |
Guo, LH | 1 |
Wang, FQ | 1 |
Yang, XG | 1 |
Tian, QS | 1 |
Sun, QH | 1 |
Miao, SS | 1 |
Fan, LJ | 1 |
Jia, SS | 1 |
Pan, Y | 1 |
Yun, W | 1 |
Shi, B | 1 |
Cui, R | 1 |
Liu, C | 1 |
Ding, Z | 1 |
Fan, J | 1 |
Jiang, W | 1 |
Tang, J | 1 |
Zheng, T | 1 |
Yu, X | 1 |
Ruano Campos, A | 1 |
Rivera Alonso, D | 1 |
Ochagavía Cámara, S | 1 |
Hu, H | 2 |
Hou, D | 1 |
Xu, H | 1 |
Li, P | 1 |
Qian, Z | 1 |
Sun, Q | 2 |
Zhao, H | 3 |
Liu, Z | 2 |
Wang, F | 2 |
Guo, L | 2 |
Tian, Q | 2 |
Fan, L | 2 |
Sun, D | 2 |
Choi, JY | 3 |
Lee, JH | 2 |
Song, Y | 1 |
Zeng, Z | 1 |
Li, K | 1 |
Ouyang, S | 1 |
Zhang, Z | 1 |
Ye, X | 1 |
Kang, W | 1 |
Yu, J | 1 |
Yuan, Z | 2 |
Miao, S | 1 |
Kim, K | 1 |
Cho, SW | 1 |
Park, YJ | 1 |
Lee, KE | 2 |
Lee, DW | 1 |
Park, SK | 2 |
Song, RY | 1 |
Yi, JW | 1 |
Yu, HW | 1 |
Kim, SJ | 1 |
Chai, YJ | 1 |
Zhou, Z | 1 |
Jiang, F | 1 |
Xie, Y | 1 |
Jiang, L | 1 |
Bogdanova, TI | 2 |
Saenko, VA | 1 |
Hirokawa, M | 2 |
Ito, M | 2 |
Zurnadzhy, LY | 1 |
Hayashi, T | 1 |
Rogounovitch, TI | 1 |
Miyauchi, A | 1 |
Tronko, MD | 2 |
Yamashita, S | 2 |
Li, H | 2 |
Huang, T | 2 |
Piccardo, A | 1 |
Giovanella, L | 1 |
Seo, M | 2 |
Kim, YS | 2 |
Lee, JC | 2 |
Han, MW | 2 |
Kim, ES | 2 |
Kim, KB | 2 |
Park, SH | 2 |
Tulchinsky, M | 1 |
Zhang, L | 1 |
Fang, C | 1 |
Liu, L | 1 |
Liu, X | 1 |
Fan, S | 1 |
Zhao, Y | 1 |
Ni, S | 1 |
Lee, DH | 1 |
Lee, YH | 1 |
Seo, HS | 1 |
Lee, KY | 1 |
Suh, SI | 1 |
Ryoo, I | 1 |
You, SH | 1 |
Kim, B | 1 |
Yang, KS | 1 |
Bai, X | 1 |
Mu, D | 1 |
Wang, J | 1 |
Lou, C | 1 |
Yan, AR | 1 |
Shen, H | 1 |
Zhou, X | 1 |
Li, R | 1 |
Veiga, LH | 1 |
Neta, G | 1 |
Aschebrook-Kilfoy, B | 1 |
Ron, E | 1 |
Devesa, SS | 1 |
Leeman-Neill, RJ | 1 |
Brenner, AV | 1 |
Little, MP | 1 |
Hatch, M | 1 |
Zurnadzy, LY | 1 |
Mabuchi, K | 1 |
Nikiforov, YE | 1 |
Fridman, MV | 1 |
Kras'ko, OV | 1 |
Man'kovskaia, SV | 1 |
Savva, NN | 1 |
Demidchik, IuE | 1 |
Liu, B | 1 |
Tilak, G | 1 |
Edwards, K | 1 |
Zhuang, H | 1 |
Jeon, YW | 1 |
Ahn, YE | 1 |
Chung, WS | 1 |
Choi, HJ | 1 |
Suh, YJ | 1 |
Sohn, SY | 2 |
Choi, JH | 1 |
Kim, NK | 1 |
Joung, JY | 1 |
Cho, YY | 1 |
Park, SM | 1 |
Kim, TH | 1 |
Jin, SM | 2 |
Bae, JC | 1 |
Lee, SY | 1 |
Bogdanova, T | 2 |
Zurnadzhy, L | 1 |
Saenko, V | 1 |
Rogounovitch, T | 1 |
Mitsutake, N | 1 |
Kondo, H | 1 |
Maeda, S | 1 |
Nakashima, M | 1 |
Tronko, M | 1 |
Haghighatafshar, M | 1 |
Farhoudi, F | 1 |
Kowalska, A | 1 |
Walczyk, A | 1 |
Kowalik, A | 1 |
Pałyga, I | 1 |
Trybek, T | 1 |
Kopczyński, J | 1 |
Kajor, M | 1 |
Chrapek, M | 1 |
Pięciak, L | 1 |
Chłopek, M | 1 |
Góźdź, S | 1 |
Kamiński, G | 1 |
Vuong, HG | 1 |
Kondo, T | 1 |
Oishi, N | 1 |
Nakazawa, T | 1 |
Mochizuki, K | 1 |
Inoue, T | 1 |
Tahara, I | 1 |
Kasai, K | 1 |
Tran, TM | 1 |
Katoh, R | 1 |
Shen, CT | 1 |
Qiu, ZL | 1 |
Song, HJ | 1 |
Wei, WJ | 1 |
Luo, QY | 1 |
Zhang, YY | 1 |
Liu, ZB | 1 |
Ye, XG | 1 |
Ren, WM | 1 |
Suat, B | 1 |
Deniz Tuna, E | 1 |
Ozgur, Y | 1 |
Muhammet, Y | 1 |
Tevfik Fikret, C | 1 |
Kim, HJ | 2 |
Park, HK | 1 |
Byun, DW | 1 |
Suh, K | 1 |
Yoo, MH | 1 |
Min, YK | 1 |
Vasileiadis, I | 1 |
Karakostas, E | 1 |
Charitoudis, G | 1 |
Stavrianaki, A | 1 |
Kapetanakis, S | 1 |
Kouraklis, G | 1 |
Karatzas, T | 1 |
Ahmed, R | 1 |
Al-Shaikh, S | 1 |
Akhtar, M | 1 |
Ceresini, G | 1 |
Corcione, L | 1 |
Michiara, M | 1 |
Sgargi, P | 1 |
Teresi, G | 1 |
Gilli, A | 1 |
Usberti, E | 1 |
Silini, E | 1 |
Ceda, GP | 1 |
Padovani, RP | 1 |
Kasamatsu, TS | 1 |
Nakabashi, CC | 1 |
Camacho, CP | 1 |
Andreoni, DM | 1 |
Malouf, EZ | 1 |
Marone, MM | 1 |
Maciel, RM | 1 |
Biscolla, RP | 1 |
Dom, G | 1 |
Tarabichi, M | 1 |
Unger, K | 1 |
Thomas, G | 1 |
Oczko-Wojciechowska, M | 1 |
Jarzab, B | 1 |
Dumont, JE | 1 |
Detours, V | 1 |
Maenhaut, C | 1 |
Jang, HW | 1 |
Suh, S | 1 |
Hur, KY | 1 |
Reviews
6 reviews available for iodine and Familial Nonmedullary Thyroid Cancer
Article | Year |
---|---|
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Topics: Humans; Iodine; Lymphatic Metastasis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyr | 2022 |
Iodine nutritional status is not a direct factor in the prevalence of the
Topics: Humans; Iodine; Mutation; Nutritional Status; Prevalence; Thyroid Cancer, Papillary; Thyroid Neoplas | 2023 |
Relationship between iodine levels and papillary thyroid carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma, Papillary; Case-Control Studies; Dietary Exposure; Humans; Iodine; Odds Ratio; Sodium Chl | 2017 |
Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status: a meta-analysis and implications.
Topics: Diet; Humans; Iodine; Nutritional Status; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2019 |
Incidentally Visualization of the Thymus on Whole-Body Iodine Scintigraphy: Report of 2 Cases and Review of the Latest Insights.
Topics: Adolescent; Adult; Carcinoma; Carcinoma, Papillary; False Positive Reactions; Female; Humans; Iodine | 2015 |
Hashimoto thyroiditis: a century later.
Topics: Carcinoma; Carcinoma, Papillary; Diet; Diseases in Twins; Female; Hashimoto Disease; Humans; Immunog | 2012 |
Trials
1 trial available for iodine and Familial Nonmedullary Thyroid Cancer
Article | Year |
---|---|
Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma.
Topics: Adult; Benzhydryl Compounds; Carcinoma, Papillary; Female; Goiter, Nodular; Humans; Iodine; Male; Ph | 2017 |
Other Studies
48 other studies available for iodine and Familial Nonmedullary Thyroid Cancer
Article | Year |
---|---|
Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Hepatocellular; Female; Humans; Iodine; Iodine Radioisotopes; | 2022 |
Iodine Maps from Dual-Energy CT to Predict Extrathyroidal Extension and Recurrence in Papillary Thyroid Cancer Based on a Radiomics Approach.
Topics: Humans; Iodine; Nomograms; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomo | 2022 |
Extreme gradient boosting model to assess risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual prediction using SHapley Additive exPlanations.
Topics: Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Reproducibility of Results; Retrospective Studies | 2022 |
Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer.
Topics: Adenosine Monophosphate; Humans; Iodides; Iodine; Iodine Radioisotopes; Morphinans; Receptors, Thyro | 2022 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Topics: Adult; Carcinoma, Papillary; Cohort Studies; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Nod | 2023 |
[Association of extranodal extension and lymph node ratio with radioactive iodine-refractory papillary thyroid cancer].
Topics: Extranodal Extension; Female; Humans; Iodine; Iodine Radioisotopes; Lymph Node Ratio; Male; Middle A | 2022 |
Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case-control study.
Topics: Case-Control Studies; Creatinine; Female; Humans; Iodine; Male; Middle Aged; Thyroid Cancer, Papilla | 2023 |
Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma.
Topics: Carcinoma, Papillary; East Asian People; Humans; Iodine; Iodine Radioisotopes; Retrospective Studies | 2023 |
High iodine effects on the proliferation, apoptosis, and migration of papillary thyroid carcinoma cells as a result of autophagy induced by BRAF kinase.
Topics: Adult; Apoptosis; Autophagy; Carcinoma, Papillary; Cell Line, Tumor; Cell Movement; Cell Proliferati | 2019 |
Strong Correlation of Abnormal Serum and Urinary Iodine Levels with Papillary Thyroid Cancer: A Case-control Study.
Topics: Adult; Case-Control Studies; China; Female; Humans; Iodine; Male; Middle Aged; Thyroid Cancer, Papil | 2020 |
Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation.
Topics: Adult; Base Sequence; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Female; | 2020 |
Cervical thyroid remnant consistent with papillary carcinoma as an incidental finding in a patient with benign total thyroidectomy ten years prior.
Topics: Female; Humans; Incidental Findings; Iodine; Middle Aged; Neoplasm Recurrence, Local; Radioisotopes; | 2019 |
Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
Topics: Adolescent; Adult; Aged; Algorithms; Decision Support Techniques; Female; Humans; Image Processing, | 2020 |
Potential role of iodine excess in papillary thyroid cancer and benign thyroid tumor: A case-control study.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Female; Humans; Iodine; Male; Middle Aged; Nutritiona | 2020 |
Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions.
Topics: Biomarkers, Tumor; Carcinoma, Papillary; Humans; Iodine; Nutrients; Thyroid Cancer, Papillary; Thyro | 2021 |
Evaluation of Iodine Status among Korean Patients with Papillary Thyroid Cancer Using Dietary and Urinary Iodine.
Topics: Adult; Diet; Humans; Iodine; Nutrition Surveys; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2021 |
Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study.
Topics: Cross-Sectional Studies; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Prognosis; Protective Fa | 2021 |
High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients.
Topics: Adult; Female; Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Retrospective S | 2021 |
Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.
Topics: Humans; Iodine; Lymph Nodes; Lymphatic Metastasis; Nomograms; Retrospective Studies; Thyroid Cancer, | 2022 |
Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study.
Topics: Case-Control Studies; Humans; Iodine; Longitudinal Studies; Thyroid Cancer, Papillary; Thyroid Neopl | 2021 |
Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
Topics: Adolescent; Adolescent Development; Age Factors; Carcinoma, Papillary; Child; Child, Preschool; Diet | 2017 |
High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk.
Topics: Adult; Autoantibodies; Carcinoma, Papillary; Female; Humans; Iodide Peroxidase; Iodine; Male; Middle | 2018 |
Re: Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
Topics: Humans; Iodine; Iodine Radioisotopes; Lymph Nodes; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a): Reply.
Topics: Humans; Iodine; Iodine Radioisotopes; Lymph Nodes; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a): Reply.
Topics: Humans; Iodine; Iodine Radioisotopes; Lymph Nodes; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
Re: Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
Topics: Humans; Iodine; Iodine Radioisotopes; Lymph Nodes; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
A case-control study of urinary levels of iodine, perchlorate and thiocyanate and risk of papillary thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Humans; Iodine; Male; Middle Aged; Odd | 2018 |
Dual-energy CT iodine quantification for characterizing focal thyroid lesions.
Topics: Adult; Biopsy, Needle; Cohort Studies; Contrast Media; Cysts; Diagnosis, Differential; Female; Human | 2019 |
Focally Increased Iodine Activity in a Small Thymic Cyst.
Topics: Adult; Diagnosis, Differential; Humans; Iodine; Male; Mediastinal Cyst; Neoplasm Metastasis; Radioph | 2019 |
High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
Topics: Disease Progression; Female; Humans; Iodine; Lymphatic Metastasis; Male; Middle Aged; Multivariate A | 2019 |
Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Topics: Adenocarcinoma, Follicular; Age Factors; Brazil; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Pa | 2013 |
RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
Topics: Adolescent; Adult; Carcinoma; Carcinoma, Papillary; Chernobyl Nuclear Accident; Child; Deficiency Di | 2013 |
[The increase of non-cancerous thyroid tissue in children and adolescents operated for papillary thyroid cancer: related factors].
Topics: Adolescent; Age Factors; Carcinoma; Carcinoma, Papillary; Child; Deficiency Diseases; Female; Fibros | 2013 |
Intense iodine activity caused by mosquito bite.
Topics: Animals; Carcinoma; Carcinoma, Papillary; Child; Culicidae; Female; Humans; Insect Bites and Stings; | 2013 |
Radioactive iodine treatment for node negative papillary thyroid cancer with capsular invasion only: Results of a large retrospective study.
Topics: Adult; Antineoplastic Agents; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine; Iodine Radioi | 2016 |
The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
Topics: Adult; Biomarkers; Carcinoma; Carcinoma, Papillary; Contrast Media; Drug Interactions; Female; Glome | 2014 |
Morphological difference in adult thyroid papillary carcinoma between Japan and Ukraine.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Cell Proliferation; Cherno | 2014 |
Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; DNA Mutational Analysis; Female; Genotype; | 2016 |
Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; DNA Mutational Analysis; Female; Gene Rearrang | 2016 |
miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.
Topics: 3' Untranslated Regions; Adult; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Cell Sur | 2016 |
Iodine regulates G2/M progression induced by CCL21/CCR7 interaction in primary cultures of papillary thyroid cancer cells with RET/PTC expression.
Topics: Adult; Carcinoma; Carcinoma, Papillary; CDC2 Protein Kinase; Cell Division; Cell Proliferation; Chem | 2016 |
The effects of radioactive iodine therapy on olfactory function.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine; Male; Middle Aged; Olfaction D | 2016 |
Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.
Topics: Academic Medical Centers; Adult; Aged; Carcinoma, Papillary; Deficiency Diseases; Diet; Female; Gene | 2018 |
Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Goiter; Greece; | 2012 |
Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.
Topics: Adenocarcinoma, Follicular; Carcinoma; Carcinoma, Papillary; Female; Humans; Incidence; Iodine; Ital | 2012 |
One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy.
Topics: Adolescent; Adult; Carcinoma; Carcinoma, Papillary; Contrast Media; Female; Humans; Iodine; Iodine C | 2012 |
A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas.
Topics: Adolescent; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Chernobyl Nuclear Accident; Child; C | 2012 |
Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Diet; Female; Humans; Iodine; Iodine Radioisotopes; Male; Mi | 2013 |